Introduction
Medication non-adherence is one of the most common yet most easily invisible problems in healthcare. The discussion is often reduced to individual patient behaviour: not forgetting the medication, not skipping doses, following the prescription correctly. However, the data shows the issue is far broader and more structural. According to the long-standing reference report by the World Health Organization, adherence to therapy for chronic diseases in developed countries sits at only around 50%. In other words, a significant share of prescribed therapies is not implemented as planned in real life.
For this reason, the commonly cited "30–50% non-adherence" range is not an exaggerated estimate but a reality repeatedly observed in the literature. Moreover, the problem is not limited to chronic diseases. A significant portion of new prescriptions is never filled at the pharmacy; antibiotic non-adherence in dental patients can affect treatment success; low compliance with post-implant care protocols can raise complication risk. The issue is not individual; it is the combination of disconnects between patient, clinical process, communication, follow-up and system design.
1. What Do the Numbers Show?
The most striking point about the prevalence of medication non-adherence is that the problem is normative rather than exceptional. WHO's 2003 data showed that adherence in chronic disease patients is only 50%. More recent systematic reviews support this picture. In a meta-analysis of patients with multimorbidity, the prevalence of medication non-adherence was calculated at 42.6%. Although there is a wide dispersion across studies, the overall pattern is clear: non-adherence is not a rare problem.
Similarly, a 2023 systematic review reported low adherence in 52.5% of participants. Factors such as male gender, low education, low income and polypharmacy were associated with higher risk. Another problem that appears even earlier is "primary non-adherence": 20–30% of new prescriptions are never filled. The treatment plan may begin on paper but never begin in practice.
Read together, these findings shift the question from "why do some patients not take their medication regularly?" to "why do healthcare systems fail to make adherence the standard instead of the exception?" Because the problem is not formed from isolated cases but from scaled, recurring patterns.
2. Why Is Non-Adherence So Widespread?
One of the most useful frameworks for understanding medication non-adherence is WHO's five-dimensional approach. In this framework, non-adherence cannot be explained by patient will alone; socioeconomic conditions, health system, disease characteristics, treatment structure and patient behaviour must be evaluated together.
The first dimension is socioeconomic factors. Low income, low health literacy, transportation difficulties and medication costs directly affect adherence. A patient may know what to do but lack the resources to sustain it. The second dimension concerns the health system. Inadequate physician–patient communication, short consultation times and the absence of follow-up mechanisms create a gap between prescribing and actually implementing the treatment.
The third dimension is the disease itself. Especially when symptoms disappear periodically or remain invisible, patients may start to perceive treatment as unnecessary. The fourth dimension is treatment structure: complex drug regimens, frequent dosing and fear of side effects weaken adherence. The final dimension concerns the patient and is the most studied in the literature. Forgetfulness is the most commonly reported barrier here; but forgetfulness often signals a deeper system problem. When protocols are complex, patient education is weak and monitoring is insufficient, forgetting ceases to be individual fault and becomes a predictable outcome.
3. Why Is It More Critical in Dentistry?
In dentistry, medication and follow-up non-adherence carries particular weight because success after many procedures depends not only on the procedure itself, but also on subsequent behaviour. Studies examining adherence to antibiotic prescriptions in dental patients show that non-adherence can have serious consequences for treatment failure and antimicrobial resistance. This reveals that non-adherence is not only individual; it also has a public-health dimension.
Source: Retrospective analysis of post-implant follow-up
In implant therapies, the picture is even more striking. A retrospective analysis reported that only 36.4% of patients attended regular maintenance visits, while 63.6% did not maintain the recommended follow-up protocol. This rate clearly shows that implant success cannot be explained by surgical technique alone. Complications such as peri-implantitis often become visible in the late period; regular follow-up visits therefore play a critical role in early detection.
The effect of certain drug groups on implant success is also important. Systematic reviews have reported that proton pump inhibitors and SSRIs may be associated with implant failure. The fact that drugs affecting bone metabolism can disrupt osseointegration shows that medication management in the dental field is important not only for prescription adherence but also for clinical risk assessment.
4. Clinical and Economic Consequences
Medication non-adherence not only disrupts treatment; it also inflates costs. A systematic review published in BMJ Open showed that annual per-person economic cost varied between $949 and $44,190 across disease groups. The all-cause non-adherence cost can rise as high as $5,271–$52,341 per person per year. These figures demonstrate that non-adherence is not just a clinical quality issue but also a resource-efficiency issue.
More recent reviews show medication non-adherence is positively associated with mortality, hospitalisation and emergency department visits. In other words, non-adherence does not produce a narrow outcome like "the drugs simply weren't finished"; it disrupts care continuity, increases complications and adds burden to the health system. The roughly 5% postoperative complication rate reported in the dental field should also be considered in this context. Not every complication is directly caused by non-adherence, but clinical risk rises when follow-up and medication management are weak.
5. Do Digital Interventions Offer a Solution?
The literature shows that digital interventions have the potential to improve medication adherence; however, their effect varies depending on the nature of the intervention. A 2025 JMIR meta-analysis calculated that mobile apps increased medication adherence in chronic patients with an effect size of Cohen's d = 0.40. This is a moderately significant effect and notable compared to behavioural interventions.
SMS and electronic reminder systems similarly yield positive results. A systematic review in JAMIA reported adherence increases in nearly all studies using SMS-based reminders. The effect is especially strong in the short term, which is notable for postoperative care and time-limited treatment protocols. Clinic-side reminder systems also produce similar improvement: a randomized controlled trial covering 283 centres showed that electronic point-of-care reminders produced a 20.6% improvement in adherence to clinical recommendations.
"When the system is not built, adherence falls; when the system is built well, behaviour improves."
That said, it would be incorrect to conclude that digital tools alone are sufficient. While the mHealth literature points broadly in a positive direction, methodological quality issues and uncertainty about long-term effects remain. The strongest takeaway is this: digital systems do not replace a well-defined care protocol; they make it more feasible and traceable.
Conclusion
It is not surprising that medication non-adherence sits at the 30–50% band; what is surprising is that this level is still treated as an individual exception. The data shows the problem is widespread, multidimensional and systemic. Income, health literacy, communication quality, treatment complexity, forgetfulness, fear of side effects and lack of follow-up are not independent; they are links of the same chain.
In dentistry this issue becomes more visible. Post-implant care, antibiotic adherence and regular check-up visits determine not only the post-operation period but the real outcome of the treatment. For this reason, adherence should be treated not as "the patient's responsibility" but as a core metric of care design. Without strong protocols, clear communication, regular follow-up and properly designed digital reminder systems, expecting high adherence is unrealistic. When the system is not built, adherence falls; when the system is built well, behaviour improves.